反应详情

To a solution of tert-butyl {1-[4-(9-phenyl-3-pyrimidin-2-yl[1,2,4]triazolo[3,4-f]-1,6-naphthyridin-8-yl)phenyl]cyclobutyl}carbamate (1-6d) (71 mg, 0.125 mmol) in MeOH (2 mL) and DCM (3 mL) was added a 4N solution of HCl in EtOAc (3 mL, 12 mmol). The sealed reaction mixture was permitted to stir at room temperature. After 4 hours the reaction mixture was concentrated. After 4 hours the reaction mixture was concentrated in vacuo. The resulting residue was purified by reverse phase column chromatography (Sunfire C18) eluting with 1 to 50% acetonitrile/(0.1% TFA/water) gradient. The appropriate fractions were concentrated in vacuo. The resulting residue was then dissolved in DCM (5 mL) & MeOH (5 mL), then added a 4N solution of HCl in EtOAc (5 mL, 20 mmol), then concentrated in vacuo to give 1-[4-(9-phenyl-3-pyrimidin-2-yl[1,2,4]triazolo[3,4-f]-1,6-naphthyridin-8-yl)phenyl]cyclobutanamine hydrochloride (1-10) as a tan solid. HRMS (M+H)+: observed=470.2098, calculated=470.2088.

1. customThe sealed reaction mixture
2. concentrationAfter 4 hours the reaction mixture was concentrated
3. concentrationAfter 4 hours the reaction mixture was concentrated in vacuo
4. customThe resulting residue was purified by reverse phase column chromatography (Sunfire C18)
5. washeluting with 1 to 50% acetonitrile/(0.1% TFA/water) gradient
6. concentrationThe appropriate fractions were concentrated in vacuo
7. dissolutionThe resulting residue was then dissolved in DCM (5 mL)
8. concentrationconcentrated in vacuo